PR Newswire: news distribution, targeting and monitoring
2014

Ateevia Botanica Is The New Daily Defense Cream Against Pain: Homeopathic Breakthrough Reduces Swelling and Inflammation

Share with Twitter Share with LinkedIn

CRESSKILL, N.J., Feb. 1, 2013 /PRNewswire/ -- Alquemiste LLC, a leading provider of patented homeopathic remedies, has launched a product to address achy joints, muscle discomfort and inflammatory pain without narcotics, steroids, smelly ointments or skin-irritating ingredients.

(Photo:  http://photos.prnewswire.com/prnh/20130201/PH52717-a ) 
(Photo:  http://photos.prnewswire.com/prnh/20130201/PH52717-b

PRIME Therapy is an all-natural topical pain reliever that reduces swelling and inflammation in joints and muscles in a short amount of time. Medical doctors, chiropractors and physical therapists recommend it to treat common pain conditions ranging from arthritis to carpal tunnel syndrome, and plantar fasciitis to sports strains, such as tennis elbow.

More Americans are affected by pain than diabetes, heart disease and cancer combined, according to the American Academy of Pain Medicine.  "Muscle and joint inflammation can be incredibly painful," says Robert Kramer, vice president of marketing for Ateevia. "On a chronic level, it can cause significant physiological damage to the human body. Ateevia's PRIME is a daily defense cream against pain.  It has the ability to shift the approach to inflammatory pain relief because the product is so safe; people tend to use it preventatively."

PRIME represents years of research and development by an anesthesiologist.  Based upon his grandfather's formula, this physician refined the treatment to make it safer, stronger, and more effective.

The cream contains a blend of organic ingredients with anti-inflammatory properties: pumpkin seed and sunflower seed extract, along with borage, poke root and safflower oil. The natural phytonutrient power of the ingredients is enhanced by Ateevia's manufacturing process.

PRIME does not contain capsaicin, a common ingredient in many pain-relieving ointments that can irritate the skin. It does not interfere with other medications. It is applied 2-3 times a day (more if the pain is chronic), by massaging a nickel-sized amount into the skin until completely absorbed.

The cream is already proving to be clinically effective. An independent university study found the therapy helped decrease pain and improve mobility in chronic pain sufferers within the first week of use.  Additionally, more than 85 percent of patients experienced significant relief within 4 weeks.

"Chronic pain can cause depression, insomnia and stress," Kramer says. "It can cause low self-esteem because a person is unable to be active. PRIME can reverse those effects by alleviating people's discomfort."

PRIME can be found in select pharmacies in New Jersey and New York and on Ateevia's website, www.ateevia.com. It will soon be available on Amazon.com and DrugStore.com.

Press Contact: Renee Sall
Maximum Exposure PR
renee@maximumexposurepr.com
201.573.0300

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.

 

SOURCE Alquemiste LLC



RELATED LINKS
http://www.ateevia.com

Featured Video

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

Share with Twitter Share with LinkedIn
 

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

 
 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

 
 

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.

 

Online Member Center

Not a Member?
Click Here to Join
Login
Search News Releases
Advanced Search
Search
  1. PR Newswire Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
  5. Send a News Release